eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
SCImago Journal & Country Rank

 
1/2009
vol. 5
 
Share:
Share:
more
 
 
abstract:

Phosphoinositide 3-kinase alterations in the thyroid gland – a review study

Katarzyna Wojciechowska-Durczyńska
,
Andrzej Lewiński

Arch Med Sci 2009; 5, 1: 10-15
Online publish date: 2009/04/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The phosphoinositide 3-kinase (PI3K) pathway has become a subject of great interest of researchers in biomedicine worldwide. Recent studies have shown that PI3K plays a crucial role in various cellular functions: cell cycle progression, cell survival, adhesion and motility, angiogenesis, glucose homeostasis, cell size and organ size control. The phosphoinositide 3-kinase pathway alterations (PIK3CA gene mutations and/or amplification) have been observed in various human tumours. In the majority of diagnosed cases, mutations are localized in one of the three “hot spots” in the gene, responsible for coding catalytic subunit a of class I PI3K (PIK3CA). Mutations in PIK3CA were confirmed in breast, colon and endometrial cancers, while mutations and amplification of the PI3KCA gene are characteristic for thyroid cancer, as well. It results in increased activity of serine-threonine kinase (Akt), followed by excessive activation of cellular functions, uncontrolled proliferation and carcinogenesis.
keywords:

PIK3CA, mutation, amplification, thyroid cancer, thyroiditis

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe